MD Anderson and Hummingbird Bioscience announce strategic research collaboration to advance innovative immunotherapies

(University of Texas M. D. Anderson Cancer Center) MD Anderson and Hummingbird Bioscience announced a multi-year strategic research collaboration to investigate HMBD-002, Hummingbird's VISTA antagonist antibody, as a novel immunotherapy for cancer.